Contract Option Exercises — September 04, 2026

Caddell's competitive win for the Ulaanbaatar embassy provides a stable ~$91.4M annual revenue stream over 5.3 years, though firm-fixed-price terms elevate execution risk.

Cost-plus-fixed-fee structure reduces financial risk for DAI, and full-and-open competition signals a strong competitive position in international development services.

The -$371,167 outlayed amount may indicate prior overpayments or accounting adjustments, warranting caution in revenue recognition.

The gap between obligated and outlayed funds suggests potential underperformance or delayed funding, and the contract has ended, limiting current revenue.

Both contracts have ended, but incumbency and NIH's continued funding for biodefense and bioinformatics suggest follow-on opportunities.

The single-year, no-option award limits material impact, but reinforces Lockheed's role in maritime security software.

Caddell's firm-fixed-price embassy contract carries high cost-overrun risk on a complex foreign construction project.

ATCC's contract ended with only 45% of obligated funds outlayed, indicating possible budget under-execution or scope changes.

The digest is heavily civilian (4 of 6 contracts), with only two defense-related awards, limiting defense sector exposure.

Lockheed Martin's non-competed award may face future competitive solicitations for PAWSS support, opening the market.

Caddell's embassy win positions it for further State Department diplomatic infrastructure projects.

DAI Global's USAID contract has options up to $520.8M, providing upside if exercised.

MANTECH's E DEFEND contract supports network defense, a growing cybersecurity priority.

ATCC's incumbency in biodefense repository services positions it for follow-on awards.

The $484.2M State Department embassy award to Caddell highlights continued investment in diplomatic infrastructure.

USAID's $357.9M award to DAI Global underscores stable funding for trade and investment initiatives in Africa.

MANTECH's $220.9M network defense order and Guidehouse's $130.2M bioinformatics support indicate sustained demand for IT services.

ATCC's $140.97M NIH contract, though ended, signals ongoing federal investment in biodefense repositories.

{"entity" => "Caddell Construction", "reason" => "Large embassy contract with high execution risk", "trigger" => "Quarterly earnings reports and project milestone updates"}

{"entity" => "DAI Global", "reason" => "USAID contract with options up to $520.8M", "trigger" => "Option exercise announcements by USAID"}

{"entity" => "MANTECH International", "reason" => "Negative outlayed amount and E DEFEND contract nearing end", "trigger" => "Re-compete or extension announcements for E DEFEND"}

{"entity" => "American Type Culture Collection", "reason" => "Incumbent on ended biodefense contract", "trigger" => "Re-compete of MID BRR contract"}

{"entity" => "Guidehouse Digital", "reason" => "Expired NIH contract; potential re-competition", "trigger" => "NIH re-competition for bioinformatics software support"}

{"entity" => "Lockheed Martin", "reason" => "Small Coast Guard order; potential follow-on", "trigger" => "Follow-on contracts for PAWSS support"}